BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 17200114)

  • 1. Protease-activating receptor-4 induces full platelet spreading on a fibrinogen matrix: involvement of ERK2 and p38 and Ca2+ mobilization.
    Mazharian A; Roger S; Berrou E; Adam F; Kauskot A; Nurden P; Jandrot-Perrus M; Bryckaert M
    J Biol Chem; 2007 Feb; 282(8):5478-87. PubMed ID: 17200114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAR4, but not PAR1, signals human platelet aggregation via Ca2+ mobilization and synergistic P2Y12 receptor activation.
    Holinstat M; Voss B; Bilodeau ML; McLaughlin JN; Cleator J; Hamm HE
    J Biol Chem; 2006 Sep; 281(36):26665-74. PubMed ID: 16837456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
    Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
    Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor-induced Akt activation--regulation and possible function.
    Reséndiz JC; Kroll MH; Lassila R
    J Thromb Haemost; 2007 Dec; 5(12):2484-93. PubMed ID: 17883592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
    Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
    Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
    Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
    Covic L; Gresser AL; Kuliopulos A
    Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor (PAR) 1 and PAR4 differentially regulate factor V expression from human platelets.
    Duvernay M; Young S; Gailani D; Schoenecker J; Hamm HE
    Mol Pharmacol; 2013 Apr; 83(4):781-92. PubMed ID: 23307185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of adenosine diphosphate in the course of thrombin signal transmission].
    Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
    Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
    Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAR1 activation initiates integrin engagement and outside-in signalling in megakaryoblastic CHRF-288 cells.
    Cichowski K; Orsini MJ; Brass LF
    Biochim Biophys Acta; 1999 Jul; 1450(3):265-76. PubMed ID: 10395938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal activation of protease-activated receptors enhances alpha2beta1 integrin-mediated platelet adhesion to collagen.
    Marjoram RJ; Voss B; Pan Y; Dickeson SK; Zutter MM; Hamm HE; Santoro SA
    J Biol Chem; 2009 Dec; 284(50):34640-7. PubMed ID: 19815553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors differentially regulate human platelet activation through a phosphatidic acid-dependent pathway.
    Holinstat M; Voss B; Bilodeau ML; Hamm HE
    Mol Pharmacol; 2007 Mar; 71(3):686-94. PubMed ID: 17151288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of protease-activated receptor 4 impairs platelet procoagulant activity during thrombus formation in human blood.
    French SL; Arthur JF; Lee H; Nesbitt WS; Andrews RK; Gardiner EE; Hamilton JR
    J Thromb Haemost; 2016 Aug; 14(8):1642-54. PubMed ID: 26878340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
    Wu CC; Wu SY; Liao CY; Teng CM; Wu YC; Kuo SC
    Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of anti-platelet activity of davallialactone: involvement of intracellular calcium ions, extracellular signal-regulated kinase 2 and p38 mitogen-activated protein kinase.
    Kim SD; Lee IK; Lee WM; Cho JY; Park HJ; Oh JW; Park SC; Kim SK; Kwak YS; Yun BS; Rhee MH
    Eur J Pharmacol; 2008 Apr; 584(2-3):361-7. PubMed ID: 18313047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML; Hamm HE
    J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of PAR4 induces a distinct actin fiber formation via p38 MAPK in human lung endothelial cells.
    Fujiwara M; Jin E; Ghazizadeh M; Kawanami O
    J Histochem Cytochem; 2005 Sep; 53(9):1121-9. PubMed ID: 15923365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.